share_log

Earnings Call Summary | Ispire Technology(ISPR.US) Q3 2024 Earnings Conference

Earnings Call Summary | Ispire Technology(ISPR.US) Q3 2024 Earnings Conference

業績電話會議摘要 | Ispire Technology (ISPR.US) 2024 年第三季度業績會議
富途資訊 ·  05/16 03:18  · 電話會議

The following is a summary of the Ispire Technology Inc. (ISPR) Q3 2024 Earnings Call Transcript:

以下是Ispire Technology Inc.(ISPR)2024年第三季度業績電話會議記錄摘要:

Financial Performance:

財務業績:

  • Ispire Technology reported Q3 revenue of $30 million, up 24% compared to the previous year.

  • Revenue in cannabis hardware saw a 57% increase, while tobacco vaping products grew by 9%.

  • Gross profit for the quarter reached $6.1 million, marking a 35% increase over last year's numbers, with an increased gross profit margin at 20.4%.

  • Despite increased revenues, operating expenses also rose considerably, resulting in a net loss of $5.9 million, a significant increase from $2.3 million net loss from last year's third quarter.

  • A $12.3 million public offering was successfully closed in March, bolstering the company's financial standing.

  • Ispire Technology公佈的第三季度收入爲3000萬美元,與去年同期相比增長24%。

  • 大麻硬件的收入增長了57%,而菸草電子煙產品的收入增長了9%。

  • 該季度的毛利達到610萬美元,比去年增長了35%,毛利率增長了20.4%。

  • 儘管收入增加,但運營支出也大幅增加,淨虧損590萬美元,較去年第三季度的230萬美元淨虧損大幅增加。

  • 3月,1,230萬澳元的公開募股成功結束,鞏固了公司的財務狀況。

Business Progress:

業務進展:

  • The company is expanding their offerings with a joint venture with Berify and Chemular, focusing on developing advanced age verification technology for e-cigarettes.

  • A collaboration with a subsidiary of Acreage Holdings is aimed at introducing Ispire ONE tech to Acreage retail facilities across the U.S.

  • The company continues to aim for additional nicotine markets with ongoing applications for pre-market tobacco product approvals.

  • A global manufacturing and distribution agreement with BrkFst is showing promising results with increased revenue and global brand awareness.

  • The company's new manufacturing facility in Malaysia, which opened in early 2024, has already started generating revenue. Despite some delays with the Ispire ONE and weaker tobacco sales, the company is expected to reach a break-even point in the upcoming quarter.

  • 該公司正在與Berify和Chemular合資擴大其產品範圍,專注於開發電子煙的高級年齡驗證技術。

  • 與Acreage Holdings子公司的合作旨在將Ispire ONE技術引入美國各地的Acreage零售設施。

  • 該公司繼續瞄準更多的尼古丁市場,並持續申請菸草製品的上市前許可。

  • 與BrkFST簽訂的全球製造和分銷協議顯示出令人鼓舞的結果,收入和全球品牌知名度都有所增加。

  • 該公司在馬來西亞的新制造工廠於2024年初開業,已經開始創造收入。儘管Ispire ONE出現了一些延誤,菸草銷售疲軟,但預計該公司將在下個季度達到盈虧平衡點。

Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.

提示:欲了解更多詳情,請訪問投資者關係網站。本文僅供投資者參考,不構成任何投資建議。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論